.BioMarin is adding kindling to the R&D fire, attacking a fit along with CAMP4 Therapeutics for l...
.Gritstone biography has generated financiers to look into "possible value-maximizing methods" after...
.Kailera Therapies has launched in to the increasingly crowded being overweight space with a profile...
.Along with very early stage 1 records right now out in bush, metabolic ailment outfit Metsera is sq...
.Rivus Pharmaceuticals has actually revealed the data responsible for its phase 2 obesity succeed in...
.Bristol Myers Squibb is paying out Top Medicine $110 million ahead of time to establish reagents fo...
.Novartis has actually printer inked a bargain likely worth more than $1 billion with Flagship-found...
.Lately debuted Metsera is unfolding some phase 1 information for its own GLP-1 receptor agonist, sh...
.Among the hereditary medications arms race, Main Pioneering is actually unveiling a brand new compa...
.BioAge Labs is looking at about $180 million in preliminary earnings coming from an IPO as well as ...